Adult nonhepatic hyperammonemia: a case report and differential diagnosis.

[1]  Cc Liu,et al.  Clinical alertness to valproic acid-induced hyperammonemia-two case reports , 2010, Journal of psychopharmacology.

[2]  V. Sundaram,et al.  Hepatic encephalopathy: pathophysiology and emerging therapies. , 2009, The Medical clinics of North America.

[3]  Roberta O'shea,et al.  What is the utility of measuring the serum ammonia level in patients with altered mental status? , 2009, Cleveland Clinic Journal of Medicine.

[4]  F. Larsen,et al.  The brain in acute liver failure. A tortuous path from hyperammonemia to cerebral edema , 2009, Metabolic Brain Disease.

[5]  M. Mehndiratta,et al.  Valproate induced non hepatic hyperammonaemic encephalopathy (VNHE)--a study from tertiary care referral university hospital, north India. , 2008, JPMA. The Journal of the Pakistan Medical Association.

[6]  D. Jensen,et al.  Cerebral edema and hyperammonemia after transjugular intrahepatic portosystemic shunt placement in a cirrhotic patient. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[7]  S. Moffatt-Bruce,et al.  Successful management of immunosuppression in a patient with severe hyperammonemia after lung transplantation. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[8]  J. Stewart.  A case of hyperammonemic encephalopathy after 11 years of valproate therapy. , 2008, Journal of clinical psychopharmacology.

[9]  I. Appollonio,et al.  Rapidly cycling encephalopathy from an almost forgotten entity , 2008, Neurological Sciences.

[10]  C. Blanke,et al.  Postchemotherapy Hyperammonemic Encephalopathy Emulating Ornithine Transcarbamoylase (OTC) Deficiency , 2008, Southern medical journal.

[11]  Kuan-Ting Liu,et al.  Postictal transient hyperammonemia. , 2008, The American journal of emergency medicine.

[12]  Y. Chawla,et al.  Minimal hepatic encephalopathy: time to recognise and treat. , 2008, Tropical gastroenterology : official journal of the Digestive Diseases Foundation.

[13]  S. Zucker,et al.  Hyperammonemic Encephalopathy Caused by Carnitine Deficiency , 2008, Journal of General Internal Medicine.

[14]  F. Lau,et al.  Two cases of valproic acid poisoning treated with l-carnitine , 2007, Human & experimental toxicology.

[15]  S. Volpato,et al.  An unusual case of hyperammonemia in a 83-year-old woman , 2007, Aging clinical and experimental research.

[16]  A. Kanner,et al.  The measurement of ammonia blood levels in patients taking valproic acid: Looking for problems where they do not exist? , 2007, Epilepsy & Behavior.

[17]  H. Poppel,et al.  Urea-splitting urinary tract infection contributing to hyperammonemic encephalopathy , 2007, Nature Clinical Practice Urology.

[18]  Anthony J. Rissling,et al.  Pharmacological and chemical effects of cigarette additives. , 2007, American journal of public health.

[19]  E. López‐Valdés,et al.  Portosystemic encephalopathy in a patient treated with peritoneal dialysis. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[20]  E. D. de Almeida,et al.  Clinical evaluation and hepatic laboratory assessment in individuals with congestive heart failure. , 2007, Arquivos brasileiros de cardiologia.

[21]  K. Pittman,et al.  Hyperammonemia encephalopathy: An important cause of neurological deterioration following chemotherapy , 2007, Leukemia & lymphoma.

[22]  William T. Hu,et al.  Ornithine transcarbamylase deficiency presenting as encephalopathy during adulthood following bariatric surgery. , 2007, Archives of neurology.

[23]  T. Nishimura,et al.  Successful portal-systemic shunt occlusion with balloon-occluded retrograde transvenous obliteration for portosystemic encephalopathy without liver cirrhosis. , 2006, Journal of vascular and interventional radiology : JVIR.

[24]  S. Fitzek,et al.  Valproic acid induced encephalopathy – 19 new cases in Germany from 1994 to 2003 – A side effect associated to VPA-therapy not only in young children , 2006, Seizure.

[25]  Y. Nieto,et al.  Idiopathic hyperammonemia following high-dose chemotherapy , 2006, Bone Marrow Transplantation.

[26]  N. Mann,et al.  A review of issues of dietary protein intake in humans. , 2006, International journal of sport nutrition and exercise metabolism.

[27]  R. Abramson,et al.  Acute Hyperammonemic Coma with Chronic Valproic Acid Therapy , 2005, The Annals of pharmacotherapy.

[28]  F. LoVecchio,et al.  L-carnitine was safely administered in the setting of valproate toxicity. , 2005, The American journal of emergency medicine.

[29]  S. Irwin,et al.  Valproic acid-associated hyperammonemic encephalopathy: a case report from the psychiatric setting. , 2005, International clinical psychopharmacology.

[30]  Y. Ubara,et al.  Hemodialysis-related portal-systemic encephalopathy. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[31]  T. Weng,et al.  Unusual causes of hyperammonemia in the ED. , 2004, The American journal of emergency medicine.

[32]  T. Saheki,et al.  Carbamoylphosphate synthetase deficiency in an adult: Deterioration due to administration of valproic acid , 1993, Journal of Inherited Metabolic Disease.

[33]  Frederick Van Lente,et al.  Correlation between ammonia levels and the severity of hepatic encephalopathy. , 2003, The American journal of medicine.

[34]  M. Raja,et al.  Valproate-induced hyperammonaemia. , 2002, Journal of clinical psychopharmacology.

[35]  W. Hwu,et al.  MRI in a case of adult-onset citrullinemia , 2001, Neuroradiology.

[36]  S. Jonnalagadda,et al.  Ornithine transcarbamylase deficiency unmasked because of gastrointestinal bleeding. , 2001, Journal of clinical gastroenterology.

[37]  P. Kaplan,et al.  Fatal Hyperammonemia after Orthotopic Lung Transplantation , 2000, Annals of Internal Medicine.

[38]  H. Makino,et al.  Fatal hyperammonemia in a patient with systemic lupus erythematosus. , 1998, Internal medicine.

[39]  M. Oechsner,et al.  Hyperammonaemic encephalopathy after initiation of valproate therapy in unrecognised ornithine transcarbamylase deficiency , 1998, Journal of neurology, neurosurgery, and psychiatry.

[40]  W. Raby.  Carnitine for valproic acid-induced hyperammonemia. , 1997, The American journal of psychiatry.

[41]  J. Wagner,et al.  Idiopathic hyperammonemia: a frequently lethal complication of bone marrow transplantation. , 1996, Bone marrow transplantation.

[42]  S. Brusilow,et al.  Hyperammonemic coma due to parenteral nutrition in a woman with heterozygous ornithine transcarbamylase deficiency. , 1995, Gastroenterology.

[43]  C. Finck,et al.  Serum analyte pattern characteristic of fulminant hepatic failure. , 1994, Annals of clinical and laboratory science.

[44]  T. Tajima,et al.  Complication of parenteral nutrition composed of essential amino acids and histidine in adults with renal failure. , 1993, JPEN. Journal of parenteral and enteral nutrition.

[45]  Lane S. Rutledge,et al.  Heterozygote ornithine transcarbamylase deficiency presenting as symptomatic hyperammonemia during initiation of valproate therapy , 1992, Neurology.

[46]  S. Cederbaum,et al.  Hyperammonemia following allogeneic bone marrow transplantation , 1991, American journal of hematology.

[47]  M. Castro‐Gago,et al.  Alteration of renal carnitine metabolism by anticonvulsant treatment , 1991, Neurology.

[48]  G. Schutze,et al.  Hyperammonemia and neonatal herpes simplex pneumonitis. , 1990, The Pediatric infectious disease journal.

[49]  F. Marumo,et al.  Lactic acidosis with hypoglycemia and hyperammonemia observed in two uremic patients during calcium hopantenate treatment. , 1990, Japanese journal of medicine.

[50]  J. Thompson,et al.  Hyperammonemic encephalopathy in urinary diversion with urea-splitting urinary tract infection. , 1990, Archives of internal medicine.

[51]  G. Cascino,et al.  Periodic hyperammonemic encephalopathy associated with a ureterosigmoidostomy. , 1989, Mayo Clinic proceedings.

[52]  Y. Ugawa,et al.  Physiological analysis of asterixis: silent period locked averaging. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[53]  S. Brusilow,et al.  Syndrome of idiopathic hyperammonemia after high-dose chemotherapy: review of nine cases. , 1988, The American journal of medicine.

[54]  T. Kugoh,et al.  Blood Ammonia Level during Valproic Acid Therapy , 1986, The Japanese journal of psychiatry and neurology.

[55]  M. Hjelm,et al.  VALPROATE-INDUCED INHIBITION OF UREA SYNTHESIS AND HYPERAMMONAEMIA IN HEALTHY SUBJECTS , 1986, The Lancet.

[56]  J. Leonard,et al.  ACUTE ENCEPHALOPATHY AND HYPERAMMONAEMIA COMPLICATING TREATMENT OF ACUTE LYMPHOBLASTIC LEUKAEMIA WITH ASPARAGINASE , 1986, The Lancet.

[57]  R. Peto.  CYTO-TOXIC CHEMOTHERAPY IN BREAST-CANCER , 1985 .

[58]  R. Grazer,et al.  Hyperammonemic encephalopathy due to essential amino acid hyperalimentation. , 1984, Archives of internal medicine.

[59]  P. Calès,et al.  Chronic vomiting in a case of citrullinaemia detected after treatment by total parenteral nutrition. , 1984, Gut.

[60]  G. Grimber,et al.  Inhibition of ureagenesis by valproate in rat hepatocytes. Role of N-acetylglutamate and acetyl-CoA. , 1983, The Biochemical journal.

[61]  J. Murphy,et al.  Asymptomatic hyperammonemia in patients receiving valproic acid. , 1982, Archives of neurology.

[62]  P. Casaer,et al.  TRANSIENT NEONATAL HYPERAMMONAEMIA AND HERPES SIMPLEX INFECTION , 1982, The Lancet.

[63]  J. Leonard,et al.  HYPERAMMONAEMIA AND DISSEMINATED HERPES SIMPLEX INFECTION IN THE NEONATAL PERIOD , 1982, The Lancet.

[64]  R. Varma,et al.  Hyperammonemic encephalopathy caused by infection in a neurogenic bladder. , 1981, The New England journal of medicine.

[65]  P. Teychenné,et al.  パーキンソン病におけるレボドーパ(単独またはカルビドーパと併用)とブロモクリプチン , 1976 .

[66]  Langeveld Mj.  Letter: Fenestrated tracheostomy tubes. , 1973 .

[67]  T. R. Brown.  ON THE RELATION BETWEEN THE VARIETY OF MICRO-ORGANISMS AND THE COMPOSITION OF STONE IN CALCULOUS PYELONEPHRITIS. , 1901 .